Zhejiang NHU Company Ltd. (SHE:002001)
China
· Delayed Price · Currency is CNY 35.08
-0.31 (-0.88%)
Apr 29, 2026, 1:25 PM CST
Zhejiang NHU Company Revenue
In the year 2025, Zhejiang NHU Company had annual revenue of 22.25B CNY with 2.97% growth. Zhejiang NHU Company had revenue of 5.61B in the quarter ending December 31, 2025, a decrease of -3.75%.
Revenue
22.25B
Revenue Growth
+2.97%
P/S Ratio
4.70
Revenue / Employee
2.01M
Employees
11,508
Market Cap
108.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.25B | 641.77M | 2.97% |
| Dec 31, 2024 | 21.61B | 6.49B | 42.95% |
| Dec 31, 2023 | 15.12B | -817.45M | -5.13% |
| Jan 1, 2023 | 15.93B | 1.02B | 6.82% |
| Jan 1, 2022 | 14.92B | 4.60B | 44.63% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sichuan Biokin Pharmaceutical | 2.52B |
| Yunnan Baiyao Group Co.,Ltd | 41.19B |
| Shanghai Fosun Pharmaceutical (Group) | 41.66B |
| Shenzhen Salubris Pharmaceuticals | 4.52B |
| Huadong Medicine | 44.06B |
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 11.67B |